Home › NDC Lookup › RxCUI directory › RxCUI 1439810

Vortioxetine 20 MG Oral Tablet — RxCUI 1439810

RxNorm drug concept · Semantic clinical drug
RxCUI 1439810 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1439810
Official nameVortioxetine 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvortioxetine (as vortioxetine hydrobromide) 20 MG Oral Tablet
FDA products mapped5
Package NDCs mapped17
Reported Medicaid activity (SDUD)354,075 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vortioxetine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trintellix is used to treat major depressive disorder — what most people call clinical depression — in adults. It's a prescription antidepressant that works on the serotonin system...
  • Antidepressants generally take several weeks to show their full effect — it's not an overnight fix. Your body reaches stable blood levels of vortioxetine within about two weeks of...
  • How long does it take for Trintellix to start working?
  • The most common side effect is nausea, which tends to be worst early on and often improves after the first week or two. You might also notice constipation, diarrhea, dry mouth, or...
📖 Read our full Vortioxetine guide →

🕸️ Concept Web — How Vortioxetine 20 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vortioxetine 20 MG Oral Tablet RxCUI 1439810

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vortioxetine 1455099
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Trintellix 1790881
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vortioxetine Oral Tablet 1439807
    • Vortioxetine Oral Product 1439805
    • Vortioxetine Pill 1439806
    • Vortioxetine Oral Tablet [Trintellix] 1790883
    • Trintellix Oral Product 1790884
    • Trintellix Pill 1790885
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vortioxetine 20 MG SCDC · 1439809
  • Vortioxetine Oral Tablet SCDF · 1439807
  • Vortioxetine Oral Product SCDG · 1439805
  • Vortioxetine Pill SCDG · 1439806

Brand-Name Concepts

  • Vortioxetine 20 MG Oral Tablet [Trintellix] SBD · 1790890
  • Vortioxetine 20 MG [Trintellix] SBDC · 1790889
  • Vortioxetine Oral Tablet [Trintellix] SBDF · 1790883
  • Trintellix Oral Product SBDG · 1790884
  • Trintellix Pill SBDG · 1790885
  • Trintellix BN · 1790881

📦 FDA Products & Package NDCs

5 products · 17 package NDCs
17 package NDCs map to RxCUI 1439810 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55154-0256-08 2520 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0256-8) Trintellix Cardinal Health 107, LLC 2013-10-02
55154-0257-08 2430 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0257-8) Trintellix Cardinal Health 107, LLC 2013-10-02
64764-0720-07 1 BOTTLE in 1 CARTON (64764-720-07) / 7 TABLET, FILM COATED... Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0720-09 30 TABLET, FILM COATED in 1 BOTTLE (64764-720-09) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0720-30 30 TABLET, FILM COATED in 1 BOTTLE (64764-720-30) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0720-77 500 TABLET, FILM COATED in 1 BOTTLE (64764-720-77) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0720-90 90 TABLET, FILM COATED in 1 BOTTLE (64764-720-90) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0730-07 1 BOTTLE in 1 CARTON (64764-730-07) / 7 TABLET, FILM COATED... Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0730-09 30 TABLET, FILM COATED in 1 BOTTLE (64764-730-09) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0730-30 30 TABLET, FILM COATED in 1 BOTTLE (64764-730-30) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0730-77 500 TABLET, FILM COATED in 1 BOTTLE (64764-730-77) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0730-90 90 TABLET, FILM COATED in 1 BOTTLE (64764-730-90) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0750-07 1 BOTTLE in 1 CARTON (64764-750-07) / 7 TABLET, FILM COATED... Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0750-09 30 TABLET, FILM COATED in 1 BOTTLE (64764-750-09) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0750-30 30 TABLET, FILM COATED in 1 BOTTLE (64764-750-30) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0750-77 500 TABLET, FILM COATED in 1 BOTTLE (64764-750-77) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
64764-0750-90 90 TABLET, FILM COATED in 1 BOTTLE (64764-750-90) Trintellix Takeda Pharmaceuticals America, Inc. 2013-10-02
Observed labelers: Takeda Pharmaceuticals America, Inc. (15) · Cardinal Health 107, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.